Bridging the translation gap - new hopes, new challenges

被引:16
|
作者
Tageja, Nishant [1 ]
机构
[1] Wayne State Univ, Dept Internal Med, Detroit Med Ctr, Detroit, MI 48201 USA
关键词
biomedical research; phase zero trials; translation gap; DRUG DEVELOPMENT; ANIMAL RESEARCH; ONCOLOGY; NXY-059; HUMANS; METAANALYSIS; STANDARDS; EFFICACY; MEDICINE; STROKE;
D O I
10.1111/j.1472-8206.2010.00903.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The complexity of modern biomedical research continues to increase. Research-to-practice gaps are now widely pervasive; these widening fissures between the disciplines of research and clinical medicine can only be abridged if the translational processes are methodically backed up by robust methods, many of which are yet to be developed. This primarily relates to the development of biomarkers, biostatistical methods, accelerated human study designs including phase 0 trials and smarter decision-making tools among other features. This brief review highlights the tribulations that have contributed to the lack of technology transfer including lapses in communication between researchers and practitioners, and related factors in service deliverance such as the health care policies, public awareness, and financing. The paper also underscores the heightened attentiveness about the problem in recent years which has, in turn, paved the road for better opportunities to enable cross-fertilization of ideas, collaboration across multiple disciplines and centers, training of students, residents and junior researchers, and promotion of practical research goals.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [21] Challenges in the New Economy: A New Era for Work Design
    Fraccaroli, Franco
    Zaniboni, Sara
    Truxillo, Donald M.
    ANNUAL REVIEW OF ORGANIZATIONAL PSYCHOLOGY AND ORGANIZATIONAL BEHAVIOR, 2024, 11 : 307 - 335
  • [22] Prescription of Statins to Women Poses New Clinical Challenges
    Pung, Madeline
    Robishaw, Janet
    Pfeffer, Marc A.
    Hennekens, Charles H.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (10) : 1139 - 1140
  • [23] New drug developments in psychosis: Challenges, opportunities and strategies
    Keshavan, Matcheri S.
    Lawler, Ashley N.
    Nasrallah, Henry A.
    Tandon, Rajiv
    PROGRESS IN NEUROBIOLOGY, 2017, 152 : 3 - 20
  • [24] Bronchodilator combinations for COPD: real hopes or a new Pandora's box?
    Roche, Nicolas
    Chanez, Pascal
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) : 1441 - 1445
  • [25] Bridging the gap: exploring the causal relationship between metformin and tumors
    Zhang, Zexin
    Wu, Wenfeng
    Wu, Zexia
    He, Yihan
    Chang, Xuesong
    Deng, Shenyuan
    Zhou, Rui
    Chen, Yadong
    Zhang, Haibo
    FRONTIERS IN GENETICS, 2024, 15
  • [26] Idiopathic pulmonary fibrosis: A new era, new challenges
    Cottin, V.
    REVUE DES MALADIES RESPIRATOIRES, 2014, 31 (07) : 583 - 586
  • [27] New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
    Chowaniec, Hanna
    Slubowska, Antonina
    Mroczek, Magdalena
    Borowczyk, Martyna
    Braszka, Malgorzata
    Dworacki, Grzegorz
    Dobosz, Paula
    Wichtowski, Mateusz
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Myasthenia gravis in 2025: five new things and four hopes for the future
    Binks, S. N. M.
    Morse, I. M.
    Ashraghi, Mohammad
    Vincent, A.
    Waters, Patrick
    Leite, M. Isabel
    JOURNAL OF NEUROLOGY, 2025, 272 (03)
  • [29] Standards for interoperability: new challenges
    Gallego-Perez, Carlos
    Cornet-Prat, Joan
    Manyach-Serra, Josep
    MEDICINA CLINICA, 2010, 134 : 32 - 38
  • [30] New challenges in modern vaccinology
    Centlivre, Mireille
    Combadiere, Behazine
    BMC IMMUNOLOGY, 2015, 16